4/A
Changes in Ownership
Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-007101
Director acquired 4,946 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DIXON WENDY L · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-17 | Grant or award : show line 1 in the form | +4,946 | $2.03 | $10,040 | 4,946 | D |
Loading xslF345X03/form4a-06302022_010603.xml…